Literature DB >> 32445314

The COVID-19 pandemic and the Tata Memorial Centre response.

.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32445314     DOI： 10.4103/ijc.IJC_250_20

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN： 0019-509X            Impact factor:   1.224


× No keyword cloud information.
  15 in total

1.  Effect of treatment interruptions and outcomes in cancer patients undergoing radiotherapy during the first wave of COVID-19 pandemic in a tertiary care institute.

Authors:  Sandip Kumar Barik; Arvind Kumar Singh; Minakshi Mishra; Adhar Amritt; Dinesh Prasad Sahu; Saroj Kumar Das Majumdar; Dillip Kumar Parida
Journal:  J Egypt Natl Canc Inst       Date:  2022-07-04

2.  Impact of the First Wave of COVID-19 Pandemic on Radiotherapy Practice at Tata Memorial Centre, Mumbai: A Longitudinal Cohort Study.

Authors:  Anil Tibdewal; Rima Pathak; Anuj Kumar; Sachith Anand; Sarbani Ghosh Laskar; Rajiv Sarin; Supriya Chopra; Reena Engineer; Siddharth Laskar; Vedang Murthy; Tejpal Gupta; Jai Prakash Agarwal
Journal:  JCO Glob Oncol       Date:  2022-07

3.  Impact of COVID-19 Pandemic on Gynecological Oncology Care: Glimpse into Association of Gynecological Oncologists of India (AGOI) Perspective.

Authors:  Geetu Bhandoria; T S Shylasree; Prashant Bhandarkar; Vijay Ahuja; Amita Maheshwari; Rupinder Sekhon; S P Somashekhar
Journal:  Indian J Gynecol Oncol       Date:  2020-06-15

4.  COVID-19 in Children with Cancer and Continuation of Cancer-Directed Therapy During the Infection.

Authors:  Badira Cheriyalinkal Parambil; Nirmalya Roy Moulik; Chetan Dhamne; Nidhi Dhariwal; Gaurav Narula; Tushar Vora; Maya Prasad; Akanksha Chichra; Shalini Jatia; Girish Chinnaswamy; Shripad Banavali
Journal:  Indian J Pediatr       Date:  2021-08-11       Impact factor: 5.319

Review 5.  SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis.

Authors:  Gaurav Seth; Saira Sethi; Shristi Bhattarai; Geetanjali Saini; Chandra Bhushan Singh; Ritu Aneja
Journal:  Cancers (Basel)       Date:  2020-11-05       Impact factor: 6.639

6.  Outcomes of Cancer Surgery During the COVID-19 Pandemic: Preparedness to Practising Continuous Cancer Care.

Authors:  C Ramachandra; Pavan Sugoor; Uday Karjol; Ravi Arjunan; Syed Altaf; Rajshekar Halkud; R Krishnappa; Purushotham Chavan; K T Siddappa; Rathan Shetty; V R Pallavi; Praveen Rathod; K Shobha; K S Sabitha
Journal:  Indian J Surg Oncol       Date:  2020-10-19

7.  Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic.

Authors:  Dorothy Lombe; Richard Sullivan; Carlo Caduff; Zipporah Ali; Nirmala Bhoo-Pathy; Jim Cleary; Matt Jalink; Tomohiro Matsuda; Deborah Mukherji; Diana Sarfati; Verna Vanderpuye; Aasim Yusuf; Christopher Booth
Journal:  Ecancermedicalscience       Date:  2021-03-11

8.  Incidence of SARS-CoV-2 infection among asymptomatic patients undergoing preoperative COVID testing prior to cancer surgery: ASPECT study.

Authors:  Shraddha Patkar; Saiesh R Voppuru; Shivakumar Thiagarajan; Devayani Niyogi; Hemant S Niranjan; Shravan Nadkarni; Tejpratap Singh; Manish Bhandare; Purvi Thakkar; Jitender Rohila; Sanjay Biswas; Sridhar Epari; Omshree Shetty; Mamta Gurav; Prachi Bapat; Ajay Puri; C S Pramesh
Journal:  J Surg Oncol       Date:  2021-11-16       Impact factor: 2.885

9.  Effect of COVID-19 Pandemic on Gynecological Cancer Radiation During Complete Nationwide Lockdown: Observations and Reflections From Tertiary Care Institute in India.

Authors:  Abhishek Shinghal; Sonz Paul; Supriya Chopra; Lavanya Gurram; Libin Scaria; Satish Kohle; Priyanka Rane; Dheera A; John Puravath; Jivanshu Jain; Jamema Swamidas; Jaya Ghosh; Sudeep Gupta; Sushmita Rath; Sarbani Ghosh Laskar; Jai Prakash Agarwal
Journal:  Adv Radiat Oncol       Date:  2021-05-28

10.  Teleoncology: The Youngest Pillar of Oncology.

Authors:  Puneet Pareek; Jeewan Ram Vishnoi; Sri Harsha Kombathula; Rakesh Kumar Vyas; Sanjeev Misra
Journal:  JCO Glob Oncol       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.